BUZZ-Zymeworks 在公布领导层变动后上涨

路透中文
Jan 12
BUZZ-Zymeworks 在公布领导层变动后上涨

1月12日 - ** 药物开发商Zymeworks ZYME.O股价上涨2.3%至23.70美元

** 公司称已任命投资行业资深人士布莱恩-切里(Brian Cherry)为董事会成员

** Cherry曾担任私募股权公司橡树山资本(Oak Hill Capital)的管理合伙人 - ZYME

** 任命 梅坎(Sabeen Mekan)博士于 2 月 1 日接替 史密斯(Jeff Smith)博士担任首席医疗官

** 马克-好莱坞(Mark Hollywood)晋升为执行副总裁兼首席运营官;任命五名新的副总裁以加强领导团队 - ZYME

** 首席财务与业务官 帕特森(Leone Patterson) 和总法律顾问 德克斯(Daniel Dex) 将于第一季度离职

** 首席执行官肯尼思-加尔布雷斯(Kenneth Galbraith)将在继任者任命之前担任代理首席财务官 - ZYME

** 截至上次收盘,股价在过去一年中上涨了约 80%

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10